A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis
2023PLoS neglected tropical diseasesJournalOpen access
10.1371/journal.pntd.0011365Full text11 citations